Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) on Monday, soared 4.26% from the previous trading day, before settling in for the closing price of $1.41. Within the past 52 weeks, IRWD’s price has moved between $1.34 and $8.64.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -3.28% over the last five years. The company achieved an average annual earnings per share of 325.00%. With a float of $154.95 million, this company’s outstanding shares have now reached $160.21 million.
The firm has a total of 253 workers. Let’s measure their productivity. In terms of profitability, gross margin is 99.71%, operating margin of 27.7%, and the pretax margin is 18.86%.
Ironwood Pharmaceuticals Inc (IRWD) Insider Activity
Observing investor behavior towards Drug Manufacturers – Specialty & Generic industry stocks is more important than anything else. The insider ownership of Ironwood Pharmaceuticals Inc is 3.17%, while institutional ownership is 102.98%. The most recent insider transaction that took place on Feb 10 ’25, was worth 244,753. In this transaction Chief Executive Officer of this company sold 139,064 shares at a rate of $1.76, taking the stock ownership to the 1,160,634 shares. Before that another transaction happened on Feb 10 ’25, when Company’s Principal Accounting Officer sold 12,048 for $1.76, making the entire transaction worth $21,204. This insider now owns 279,655 shares in total.
Ironwood Pharmaceuticals Inc (IRWD) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.04 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 325.00% per share during the next fiscal year.
Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) Trading Performance Indicators
Ironwood Pharmaceuticals Inc (IRWD) is currently performing well based on its current performance indicators. A quick ratio of 4.69 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.67. Likewise, its price to free cash flow for the trailing twelve months is 2.27.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.01, a number that is poised to hit -0.03 in the next quarter and is forecasted to reach 0.22 in one year’s time.
Technical Analysis of Ironwood Pharmaceuticals Inc (IRWD)
Analysing the last 5-days average volume posted by the [Ironwood Pharmaceuticals Inc, IRWD], we can find that recorded value of 1.69 million was lower than the volume posted last year of 3.29 million. As of the previous 9 days, the stock’s Stochastic %D was 44.94%. Additionally, its Average True Range was 0.14.
During the past 100 days, Ironwood Pharmaceuticals Inc’s (IRWD) raw stochastic average was set at 3.94%, which indicates a significant decrease from 58.82% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 62.56% in the past 14 days, which was lower than the 109.14% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.0309, while its 200-day Moving Average is $4.0964. Now, the first resistance to watch is $1.5433. This is followed by the second major resistance level at $1.6167. The third major resistance level sits at $1.7283. If the price goes on to break the first support level at $1.3583, it is likely to go to the next support level at $1.2467. Should the price break the second support level, the third support level stands at $1.1733.
Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) Key Stats
Market capitalization of the company is 235.24 million based on 160,028K outstanding shares. Right now, sales total 351,410 K and income totals 1,810 K. The company made 90,550 K in profit during its latest quarter, and 3,190 K in sales during its previous quarter.
